179 related articles for article (PubMed ID: 11747248)
1. Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.
Mallol J; Aguirre V; Rhem R; Rodriguez J; Dolovich M
Pediatr Pulmonol; 2001 Dec; 32(6):447-52. PubMed ID: 11747248
[TBL] [Abstract][Full Text] [Related]
2. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
3. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
5. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
[TBL] [Abstract][Full Text] [Related]
6. Effect of different inhaled bronchodilators on recovery from methacholine-induced bronchoconstriction in asthmatic children.
Quezada A; Mallol J; Moreno J; Rodriguez J
Pediatr Pulmonol; 1999 Aug; 28(2):125-9. PubMed ID: 10423312
[TBL] [Abstract][Full Text] [Related]
7. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
8. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
9. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
Creticos PS; Adams WP; Petty BG; Lewis LD; Singh GJ; Khattignavong AP; Molzon JA; Martinez MN; Lietman PS; Williams RL
J Allergy Clin Immunol; 2002 Nov; 110(5):713-20. PubMed ID: 12417879
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
Ahrens RC; Hendeles L; Clarke WR; Dockhorn RJ; Hill MR; Vaughan LM; Lux C; Han SH
Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
[TBL] [Abstract][Full Text] [Related]
11. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.
Newhouse MT; Patel P; Parry-Billings M
Eur Respir J; 2003 May; 21(5):816-20. PubMed ID: 12765427
[TBL] [Abstract][Full Text] [Related]
12. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
13. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
16. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
17. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children.
Avital A; Godfrey S; Schachter J; Springer C
Pediatr Pulmonol; 1994 May; 17(5):281-4. PubMed ID: 8058420
[TBL] [Abstract][Full Text] [Related]
19. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of in vivo bioequivalence of a generic albuterol metered-dose inhaler to Ventolin.
Stewart BA; Ahrens RC; Carrier S; Frosolono M; Lux C; Han SH; Milavetz G
Chest; 2000 Mar; 117(3):714-21. PubMed ID: 10712996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]